Dr. Sherif Fahmy stands among the most accomplished academic leaders and innovators shaping the future of healthcare, pharmaceuticals, and artificial intelligence.

Dr. Fahmy serves as Professor of Pharmacy and Dean for Scientific Affairs at the University of Nottingham, a position he has held since 2010.

As an entrepreneur, he co-founded Biocity Limited, the United Kingdom’s largest science incubator valued at $37 million, playing a strategic role in nurturing hundreds of startups and research ventures.

In 2020, he launched AI Pharma Ltd, now valued at $23 million, driving forward the integration of artificial intelligence in drug discovery, pharmaceutical modeling, and predictive therapeutics.

Known for his pioneering work in AI-driven healthcare and biotechnology, Dr. Fahmy has founded three successful biotech companies in the UK and UAE, reinforcing his influence as a leader at the crossroads of science, entrepreneurship, and technology. His recent election as a Board Member of the Dubai AI Campus, the region’s largest government-backed AI cluster, further strengthens his role in shaping the future of AI in the Middle East.

“Dr. Sherif Fahmy represents the powerful intersection of science, innovation, and artificial intelligence. His leadership from academia to industry perfectly reflects the mission of AI in Dubai 2026,” says Dr. Hikmat Beaini, President of the AI in Dubai Conference.

“AI is redefining what is possible in medicine, and together, we can accelerate discovery, improve health outcomes, and shape a smarter future,” says Dr. Fahmy